Salomon & Ludwin
IONS icon

Salomon & Ludwin’s Ionis Pharmaceuticals IONS Stock Holding History

Salomon & Ludwin’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.8K Hold
332
– – ﹤0.01% 1126
2026
Q2 		$26.3K Hold
332
– – ﹤0.01% 946
2026
Q1 		$24.8K Hold
332
– – ﹤0.01% 931
2025
Q4 		$26.1K Hold
332
– – ﹤0.01% 702
2025
Q3 		$23K Buy
+332
New +$16.2K ﹤0.01% 732

Other funds holding IONS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Tweedy, Browne Co
Tweedy, Browne Co Stamford, Connecticut $1.23B AUM 16.54% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Privium Fund Management
Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return

Salomon & Ludwin's IONS Position: Q3 2026 in Review

Salomon & Ludwin held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 332 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1126.

Salomon & Ludwin first reported a position in IONS in Q3 2025 and has held it in 5 quarters since. The position peaked at $26.3K in Q2 2026. 175 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Salomon & Ludwin held 332 shares of Ionis Pharmaceuticals worth $14.8K as of Q3 2026.
  • Salomon & Ludwin left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #1126 holding.
  • Salomon & Ludwin first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Salomon & Ludwin's Ionis Pharmaceuticals position peaked at $26.3K in Q2 2026.
  • 175 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.